Versanis Bio Announces Completion of Enrollment of the BELIEVE Phase 2b Study in Patients with Obesity

/PRNewswire/ -- Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for obesity and other cardiometabolic...

Related Keywords

Mark Pruzanski ,Prnewswire Versanis Bio ,Ken Attie , ,Versanis Bio ,